Status:
RECRUITING
The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.
Lead Sponsor:
Rakitzi, Stavroula
Conditions:
Anxiety
Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.
Detailed Description
Reintegration into society and good functional outcome by people with mental health disorders is frequently the result of the combination of pharmacotherapy and individual cognitive behavioral psychot...
Eligibility Criteria
Inclusion
- age 18-65,
- IQ ≥ 80,
- Diagnosis: anxiety disorders, depression, obsessive-compulsive disorders, PTSD, personality disorders, bipolar disorders, schizophrenia and psychotic disorders.
Exclusion
- \*Substance abuse and head injury.
Key Trial Info
Start Date :
June 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06993662
Start Date
June 2 2025
End Date
December 20 2027
Last Update
July 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE
Athens, Greece, 15771